Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

IND clearance for squalamine in neovascular diseases of the eye

April 26, 2004

Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment

April 26, 2004

Gatiflo eye drops receive Japanese approval

April 23, 2004

Alcon claims new 5-HT2 receptor agonists and their use as IOP lowering agents

April 20, 2004

New prostanoid EP4 agonists for glaucoma therapy claimed by Merck Frosst

April 19, 2004

Orphan drug status for microplasmin in pediatric eye surgery

April 6, 2004

SnET2-PDT NDA submitted for AMD

April 5, 2004

Lupin to promote Zymar to U.S. pediatricians

April 2, 2004

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

March 16, 2004

Iquix receives FDA approval for bacterial corneal ulcer

March 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...